Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 11,636 |
| Marketable Securities | N/A | 10,023 |
| Receivables | N/A | 13,167 |
| Inventories | N/A | 4,093 |
| Other current assets | 0 | 1,955 |
| TOTAL | $N/A | $40,874 |
| Non-Current Assets | ||
| PPE Net | N/A | 5,849 |
| Other Non-Current Assets | 0 | 43,556 |
| TOTAL | $N/A | $49,405 |
| Total Assets | $N/A | $89,413 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 8,119 |
| Accrued Expenses | N/A | 8,581 |
| Other current liabilities | N/A | 4,375 |
| TOTAL | $N/A | $21,155 |
| Non-Current Liabilities | ||
| Long Term Debt | N/A | 24,466 |
| Other Non-Current Liabilities | 0 | 72,678 |
| TOTAL | $N/A | $98,417 |
| Total Liabilities | $N/A | $119,572 |
| Shareholders' Equity | ||
| Common Shares | N/A | 1 |
| Retained earnings | N/A | -31,413 |
| Other shareholders' equity | 0 | 1,253 |
| TOTAL | $N/A | $-30,159 |
| Total Liabilities And Equity | $0 | $89,413 |